October 2017

Breakthrough: An Inside look at CAR T Cell Immunotherapy

Relapsed Pre-B cell acute lymphoblastic leukemia (ALL) has a notoriously low remission rate—but now, thanks to childhood cancer researchers and the FDA, there is more hope on the horizon. 

In August 2017, the FDA approved CAR (Chimeric Antigen Receptor) T Cell immunotherapy as a treatment for certain types of ALL. This is the first gene therapy to achieve FDA approval in the United States and one of the few major breakthroughs and approvals for pediatric oncology in recent years. 

Help Us Scare Away Childhood Cancer

Monsters are scary, but childhood cancer is scarier. Childhood cancer is the number one cause of death by disease in children in the United States. During the month of October, over 20,000 children (nearly 700 a day!) will be affected by an initial or recurrent diagnosis of childhood cancer. Research is needed and it is needed NOW. 

Together, we can change this scary fact and work together towards cures

Seven Things $1 Million Can Do For Children With Cancer


During Alex’s Million Mile in September, supporters raised over $1 million for childhood cancer research and supportive services for families! All year long, Alex’s Lemonade Stand Foundation (ALSF) uses this money to fund projects at every stage of research to ensure cures are being found today and for the future. 

Here are seven ways $1 million helps children with cancer: